ID29970A - Metode untuk mengobati penyakit neovaskuler okuler - Google Patents

Metode untuk mengobati penyakit neovaskuler okuler

Info

Publication number
ID29970A
ID29970A IDW00200101090A ID20011090A ID29970A ID 29970 A ID29970 A ID 29970A ID W00200101090 A IDW00200101090 A ID W00200101090A ID 20011090 A ID20011090 A ID 20011090A ID 29970 A ID29970 A ID 29970A
Authority
ID
Indonesia
Prior art keywords
treating
oulner
methods
neovascular disease
neovascular
Prior art date
Application number
IDW00200101090A
Other languages
English (en)
Inventor
Romulus Kimbro Brazzell
Jeanette Marjorie Wood
Peter Anthony Campochiaro
Frances Elizabeth Kane
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of ID29970A publication Critical patent/ID29970A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IDW00200101090A 1998-11-23 1999-11-22 Metode untuk mengobati penyakit neovaskuler okuler ID29970A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19867798A 1998-11-23 1998-11-23

Publications (1)

Publication Number Publication Date
ID29970A true ID29970A (id) 2001-10-25

Family

ID=22734344

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW00200101090A ID29970A (id) 1998-11-23 1999-11-22 Metode untuk mengobati penyakit neovaskuler okuler

Country Status (19)

Country Link
EP (1) EP1131073B1 (id)
JP (2) JP2002530342A (id)
KR (1) KR100698449B1 (id)
CN (1) CN1172673C (id)
AT (1) ATE252387T1 (id)
AU (1) AU761092B2 (id)
BR (1) BR9915569A (id)
CA (1) CA2348890C (id)
DE (1) DE69912304T2 (id)
DK (1) DK1131073T3 (id)
ES (1) ES2211197T3 (id)
HK (1) HK1040182A1 (id)
ID (1) ID29970A (id)
IL (2) IL142757A0 (id)
NO (1) NO328085B1 (id)
NZ (1) NZ511559A (id)
PT (1) PT1131073E (id)
WO (1) WO2000030651A1 (id)
ZA (1) ZA200103925B (id)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0122318D0 (en) * 2001-09-14 2001-11-07 Novartis Ag Organic compounds
US20030119812A1 (en) * 2001-11-08 2003-06-26 Brazzell Romulus Kimbro Method for decreasing capillary permeability in the retina
JP2005536516A (ja) * 2002-07-23 2005-12-02 ノバルティス アクチエンゲゼルシャフト 薬剤、軟膏基剤および可溶化剤／分散剤を含む、眼科用軟膏組成物
MX2007001155A (es) * 2004-07-29 2007-08-14 Creabilis Therapeutics Spa Uso de inhibidores de k-252a y de quinasa para la prevencion o el tratamiento de patologias asociadas con hmgb1.
CN101580515B (zh) * 2008-05-16 2011-06-08 上海医药工业研究院 一种星形孢菌素提取纯化的方法
WO2010104933A1 (en) 2009-03-11 2010-09-16 Merck Sharp & Dohme Corp. Inhibitors of akt activity
WO2010114780A1 (en) 2009-04-01 2010-10-07 Merck Sharp & Dohme Corp. Inhibitors of akt activity
CN102924479A (zh) * 2011-08-09 2013-02-13 山东鲁北药业有限公司 一种星孢菌素类衍生物的半合成方法
US9345705B2 (en) 2011-09-15 2016-05-24 Merck Sharp & Dohme Corp. Compositions and methods for treating cancer
AU2013352568B2 (en) 2012-11-28 2019-09-19 Merck Sharp & Dohme Llc Compositions and methods for treating cancer

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5093330A (en) * 1987-06-15 1992-03-03 Ciba-Geigy Corporation Staurosporine derivatives substituted at methylamino nitrogen
IL86632A0 (en) * 1987-06-15 1988-11-30 Ciba Geigy Ag Derivatives substituted at methyl-amino nitrogen
WO1994001124A1 (en) * 1992-07-08 1994-01-20 Celtrix Pharmaceuticals, Inc. METHOD OF TREATING OPHTHALMIC DISORDERS USING TGF-$g(b)
US6410322B1 (en) * 1993-07-27 2002-06-25 Hybridon Inc Antisense oligonucleotide inhibition of vascular endothelial growth factor expression
AU2066797A (en) * 1996-03-21 1997-10-10 Sugen, Inc. Assays for kdr/flk-1 receptor tyrosine kinase inhibitors
UA54427C2 (uk) * 1996-05-01 2003-03-17 Елі Ліллі Енд Компані Спосіб лікування очних захворювань, які пов'язані з фактором васкулярного ендотеліального росту
CA2321560C (en) * 1998-03-13 2007-05-22 Johns Hopkins University School Of Medicine The use of a protein tyrosine inhibitor such as genistein in the treatment of diabetic retinopathy or ocular inflammation

Also Published As

Publication number Publication date
IL142757A0 (en) 2002-03-10
EP1131073A1 (en) 2001-09-12
DE69912304T2 (de) 2004-07-22
AU1506600A (en) 2000-06-13
NO20012490L (no) 2001-06-25
AU761092B2 (en) 2003-05-29
PT1131073E (pt) 2004-03-31
DE69912304D1 (de) 2003-11-27
NZ511559A (en) 2004-01-30
IL142757A (en) 2007-07-04
JP2002530342A (ja) 2002-09-17
ATE252387T1 (de) 2003-11-15
CA2348890C (en) 2009-05-12
EP1131073B1 (en) 2003-10-22
JP2011088938A (ja) 2011-05-06
CN1328462A (zh) 2001-12-26
CA2348890A1 (en) 2000-06-02
NO20012490D0 (no) 2001-05-21
HK1040182A1 (en) 2002-05-31
KR100698449B1 (ko) 2007-03-23
ES2211197T3 (es) 2004-07-01
ZA200103925B (en) 2002-07-25
NO328085B1 (no) 2009-11-30
WO2000030651A1 (en) 2000-06-02
KR20010078398A (ko) 2001-08-20
BR9915569A (pt) 2001-08-14
DK1131073T3 (da) 2004-02-02
CN1172673C (zh) 2004-10-27

Similar Documents

Publication Publication Date Title
DE60138137D1 (de) Verfahren und zusammensetzungen zur behandlung von okularer neovaskularisierung und nervenverletzungen
LU91928I2 (fr) Ipilimumab et ses dérivés pharmaceutiquement acceptables (YERVOY®)
DK0841949T3 (da) Anvendelse af saccharid-konjugater
DE69834658D1 (de) Verwendung von aminothiolverbindungen zur behandlung von nerven- und nieren-erkrankungen und der arzneimitteltoxizität
PT971713E (pt) Utilizacao de inibidores da colinesterase para tratamento de desordens da atencao
ECSP045098A (es) Procedimientos para tratar enfermedades neovasculares oculares
DE60027431D1 (de) Verwendung von p38 MAPK Inhibitoren in der Behandlung von Augenkrankheiten
BR9811012A (pt) "uso de um composto".
AP2002002596A0 (en) Piperazine and piperidine derivatives.
ATE144898T1 (de) Behandlung neurodegenerativer krankheiten
AP2004003124A0 (en) Thiazole and oxazole derivatives which modulate PPAR activity
BR0210241A (pt) Piranoindazóis e seu uso no tratamento de glaucoma
NO990912D0 (no) Terapeutiske kombinasjoner av PAR-antagonister og RXR-antagonister og deres anvendelse
MY119375A (en) Treatment of tinnitus using neuroprotective agents
BR0109499A (pt) Tratamento melhorado de neovascularização
ID29970A (id) Metode untuk mengobati penyakit neovaskuler okuler
DE69613386T2 (de) Carbostyrilderivat zur behandlung von ophthalmologischen erkrankungen
WO2000009098A3 (en) Method for treating ocular neovascular diseases
EE200100026A (et) Oksasolidinoonid silmahaiguste raviks
AU2001267864A1 (en) Remedial agent for optic nerve disease and the like
SE9403160D0 (sv) Method and means for prevention and treatment of secondary cataract
DE69916013D1 (de) Vorderkammerimplantat zur behandlung des phaken auges
DE60215864D1 (de) Behandlung von okularen neovaskularen erkrankungen
BR0215752A (pt) Piranoindazóis e seu uso no tratamento de glaucoma
DE69635282D1 (de) Behandlung der exzessiven aggressivität mit olanzapine